ArticlePloS one2026
Apple-derived miR-482a-3p decreases c-MYB expression and proliferation of human intestinal cell lines.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are small endogenous RNAs involved in gene expression modulation at post-transcriptional level, regulating several biological processes ranging from differentiation to proliferation and preservation of cell and tissue identity. Evidence describe the ability of miRNAs to move between organisms of distinct species, a phenomenon referred to as "trans-kingdom" exchange. Notably, plant miRNAs can be transferred to other species, including humans, and potentially target and modulate genes. Here, we investigated for the first time the trans-kingdom capability of apple-derived microRNAs (miRNAs) to influence human intestinal cells (HT-29 and HCT116) in vitro. Our data demonstrate that synthetic apple-derived miR-482a-3p and miR-858 can be internalized by human colonic cell lines and significantly reduce cell proliferation. Through an in silico analysis followed by gene expression and luciferase reporter assays, we show that apple-derived miR-482a-3p targets the human c-MYB gene in intestinal cell lines, thereby directly contributing to the regulation of the enterocyte cell cycle. This study supports the trans-kingdom hypothesis by providing evidence that plant-derived miRNAs can directly modulate enterocyte lifespan and metabolic activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.